Cargando…
The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers
The Prostate Urine Risk (PUR) biomarker is a four-group classifier for predicting outcome in patients prior to biopsy and for men on active surveillance. The four categories correspond to the probabilities of the presence of normal tissue (PUR-1), D’Amico low-risk (PUR-2), intermediate-risk (PUR-3),...
Autores principales: | Ball, Richard Y., Cardenas, Ryan, Winterbone, Mark S., Hanna, Marcelino Y., Parker, Chris, Hurst, Rachel, Brewer, Daniel S., D’Sa, Lauren, Mills, Rob, Cooper, Colin S., Clark, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622091/ https://www.ncbi.nlm.nih.gov/pubmed/34833048 http://dx.doi.org/10.3390/life11111172 |
Ejemplares similares
-
Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer
por: Yazbek Hanna, Marcelino, et al.
Publicado: (2023) -
A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
por: Connell, Shea P., et al.
Publicado: (2019) -
Transcodeur BCD - binaire pur
por: Tiger, F
Publicado: (1970) -
Le pur et l'impur /
por: Jankélévitch, Vladimir
Publicado: (1978) -
Une tête pur le CERN
Publicado: (1999)